Da Vinci Robotic Surgery Lawsuit: Claims, Payouts, and Timing

If you or a family member were hurt during a robotic operation, a da Vinci robotic surgery lawsuit typically falls into one of two tracks: a product liability claim against the device’s manufacturer, Intuitive Surgical, or a medical malpractice claim against the hospital and surgeon. Thousands of claims have been filed over the past decade alleging burns, organ perforations, and deaths, and Intuitive set aside $67 million in 2014 to resolve a large batch of them through mediation.¹ The product liability wave has largely wound down, and many firms are no longer taking new manufacturer cases, but malpractice suits against hospitals and surgeons continue to produce verdicts, and a separate antitrust class action by hospital purchasers is still active as of 2026.

What the Lawsuits Have Alleged

The injuries at the heart of these cases share a pattern. Plaintiffs have described electrical current arcing from the EndoWrist instruments into surrounding tissue, burning organs the surgeon could not see. Others have alleged control freezes, malfunctioning arms, faulty surgical tips, and broken instrument pieces falling into patients during procedures.²

The reporting data behind those allegations is substantial. A peer-reviewed study of the FDA’s MAUDE database from 2000 through 2013 counted 10,624 adverse event reports tied to robotic surgery: about 76% involved device malfunctions, 13% patient injuries, and 1.4% patient deaths. The most common malfunctions were broken instrument pieces (roughly 15%), electrical arcing or damaged tip covers (about 11%), and instruments moving without the surgeon’s command (about 9%). Roughly 10% of events led to interrupted or converted surgeries, and the researchers warned the database understates the real total.³ By 2018, cumulative adverse event reports had passed 20,000, with more than 2,000 classified as serious injuries and 274 involving patient deaths.²

Product liability complaints against Intuitive have generally advanced three theories:

Design defect, particularly cracks or failures in the insulation covering the robotic arms that allowed electrical current to leak.²
Failure to warn hospitals, surgeons, and patients about known risks.
Inadequate training, with plaintiffs pointing out that experts in Washington State litigation testified a surgeon typically needs 150 to 250 procedures before real confidence with the device develops, while Intuitive’s own requirement was just two proctored surgeries.⁴

One important caveat comes from the litigation data itself. A study of 108 product liability claims filed against Intuitive between 2000 and 2017 found that actual device malfunction was cited in only 2 of the 108. The rest turned on surgical complications, which the researchers said pointed more toward training gaps and the learning curve than to defects in the hardware. About 35% of the claims in that dataset were dismissed.⁵

Suing the Manufacturer vs. Suing the Hospital

Patients injured during a da Vinci procedure usually face a choice between two legal theories, and many pursue both at once.

A product liability claim targets Intuitive Surgical, alleging that a defect in the device itself caused the injury, that the company failed to warn about known risks, or that its training program was inadequate.⁵ A medical malpractice claim targets the surgeon or hospital, alleging negligence in operating the device, failing to recognize complications, or failing to obtain informed consent about robotic-specific risks.

The line between the two can be difficult to draw. When a bowel perforation happens during a robotic prostatectomy, it is often unclear whether the cause was surgical technique, a mechanical failure the surgeon could not see, or some combination. A 2013 study cited in the litigation attributed 21% of robotic surgery complications to physician error and 14% to failures of the robot itself. Juries have split fault across multiple defendants; in a 2025 Florida case, a jury assigned 40% fault to the surgeon, 40% to a nurse staffing agency, and 20% to the hospital after a woman died from sepsis following a robotic hysterectomy.⁶

One legal development worth knowing about is the Washington Supreme Court’s February 2017 ruling in Taylor v. Intuitive Surgical. The court held that under Washington’s Product Liability Act, a manufacturer has an independent duty to warn the purchasing hospital about a device’s risks, and that strict liability, not negligence, governs failure-to-warn claims under the state statute. The court rejected Intuitive’s argument that warning the surgeon alone was enough.⁴

What Cases Have Paid Out

Federal plaintiffs asked the U.S. Judicial Panel on Multidistrict Litigation to consolidate da Vinci cases into an MDL, but the panel denied that request in August 2012. Cases have proceeded individually in courts around the country rather than under a single federal judge.¹

Intuitive has never lost a product liability verdict at trial. The first case to reach a jury, Taylor v. Intuitive Surgical, ended with a 2013 defense verdict in Washington State (later vacated on the failure-to-warn issue described above). The second, Zarick v. Intuitive Surgical in Santa Clara County, settled on confidential terms during the third day of jury deliberations in April 2016. Michelle Zarick had alleged that an electrified scissor attachment injured her bowel during a 2009 hysterectomy; her attorneys had originally sought $300 million and asked the jury for $30 million in closing.⁷ Plaintiff’s counsel Mark Geragos said the settlement could help resolve about 20 other pending suits.⁸

The biggest publicly disclosed resolution came the same period. In 2014, Intuitive disclosed in financial reports that it had received roughly 3,000 product liability claims covering surgeries performed between 2004 and 2013, and it set aside $67 million to settle those claims through mediation. How the fund was divided among individual claimants was not disclosed.¹

Publicly reported verdicts and settlements against Intuitive, hospitals, and surgeons give some sense of the range:

2012, Illinois: $7.5 million verdict.
2018, Indiana: $1.04 million total, with $250,000 from Intuitive and $790,000 from the state patient compensation fund.
2019, Illinois: $3 million verdict.
2021, Virginia: $700,000 settlement.
2025, Florida: over $1.2 million awarded after a sepsis death following a robotic hysterectomy.

These figures were compiled from publicly available case records and reporting.⁶

Not every recent case has stuck. Harvey Sultzer sued Intuitive in the Southern District of Florida in early 2024 after his wife Sandra died in February 2022, alleging that during her September 2021 colon cancer surgery at Baptist Health Boca Raton Regional Hospital, an insulation defect let the device burn and tear her small intestine.⁹¹⁰ He agreed to dismiss the case in July 2024, and the reason was not publicly disclosed.¹¹

Why Timing Matters More Than People Expect

Statute of limitations problems have knocked out plaintiffs who thought they were protected. In Rustico v. Intuitive Surgical, the Ninth Circuit affirmed summary judgment for Intuitive in 2021 under California’s two-year limitations period. Intuitive had offered a general tolling agreement to claimants, but the tolling did not start running until a claimant’s name was formally submitted. The Rusticos’ lawyer signed the agreement but did not submit their names until more than two years after the 2012 surgery, and by then the clock had already run out.¹² The lesson for anyone considering a claim is that the deadline is short, it varies by state, and signing paperwork does not automatically stop the clock.

Where Things Stand Now

The product liability wave that peaked around 2013 has mostly subsided. New claim volume dropped sharply after 2015, and by 2017 only a single new product liability claim appeared in one study’s dataset.⁵ Intuitive’s SEC filings as of early 2024 still listed approximately 93 active lawsuits, but many law firms are no longer soliciting new da Vinci product liability cases.¹

Two areas of activity remain. Malpractice suits against hospitals and surgeons involving the da Vinci system continue to produce verdicts and settlements, as the 2025 Florida outcome shows. And a separate antitrust class action by hospital purchasers, alleging that Intuitive illegally tied service and EndoWrist instrument sales to the da Vinci system, was certified on March 31, 2025 by U.S. District Judge Araceli Martínez-Olguin. The certified class covers entities that purchased Intuitive’s da Vinci service and EndoWrist products in the United States between May 2017 and December 2021, excluding hospitals operated by the Departments of Defense and Veterans Affairs.¹³ That case is a dispute between hospitals and Intuitive over pricing and service, not a route for injured patients to recover.

For anyone weighing a claim over an injury from a da Vinci procedure today, the practical path usually runs through a medical malpractice attorney evaluating the surgeon’s and hospital’s conduct, rather than a mass-tort product liability filing against Intuitive. State deadlines are short, and the Rustico ruling is a reminder that generic tolling paperwork may not do what a claimant assumes it does.

1
Drugwatch. Da Vinci Surgery Lawsuits
2
FindLaw. Da Vinci Robot Surgery Lawsuits
3
National Library of Medicine. Adverse Events in Robotic Surgery: A Retrospective Study of the FDA MAUDE Database
4
Washington Courts. Taylor v. Intuitive Surgical Inc.
5
National Library of Medicine. Analysis of Product Liability Litigation Involving Robotic Surgical Systems
6
Miller & Zois. Da Vinci Malpractice Lawsuits
7
Courtroom View Network. Surgical Robot Defect Trial Settles During Jury Deliberations
8
MassDevice. Intuitive Surgical Settles Product Liability Lawsuit Ahead of Verdict
9
People. Da Vinci Surgical Robot Lawsuit
10
NBC News. Robotic Device Burned Woman’s Small Intestine During Surgery, Lawsuit Alleges
11
Law360. Sultzer v. Intuitive Surgical Inc.
12
U.S. Court of Appeals for the Ninth Circuit. Rustico v. Intuitive Surgical Inc.
13
Cohen Milstein. Buyer Class of Surgical Robots Is Certified in Antitrust Fight